Cargando…

Temporal trends in microbial detection during the COVID-19 pandemic: Analysis of the Japan surveillance for Infection Prevention and Healthcare Epidemiology (J-SIPHE) database

The impact of the COVID-19 pandemic on the incidence of microbial infections and other metrics related to antimicrobial resistance (AMR) has not yet been fully described. Using data from Japan Surveillance for Infection Prevention and Healthcare Epidemiology (J-SIPHE), a national surveillance databa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Endo, Akira, Asai, Yusuke, Tajima, Taichi, Endo, Mio, Akiyama, Takayuki, Matsunaga, Nobuaki, Ishioka, Haruhiko, Tsuzuki, Shinya, Ohmagari, Norio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. 2023
Materias:	Note
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9472589/ https://www.ncbi.nlm.nih.gov/pubmed/36113846 http://dx.doi.org/10.1016/j.jiac.2022.08.028

Ejemplares similares

908. Evaluation of Blood Culture Submission Rates in Japan
por: Tajima, Taichi, et al.
Publicado: (2020)

223. Difference in Carbapenem Use by ASP Intervention in Japanese Healthcare Facilities
por: Endo, Mio, et al.
Publicado: (2020)

Impact of regional heterogeneity on the severity of COVID-19
por: Tsuzuki, Shinya, et al.
Publicado: (2022)

Comparison of the clinical characteristics and outcomes of COVID-19 in children before and after the emergence of Delta variant of concern in Japan
por: Shoji, Kensuke, et al.
Publicado: (2022)

Improved penicillin susceptibility of Streptococcus pneumoniae and increased penicillin consumption in Japan, 2013–18
por: Tsuzuki, Shinya, et al.
Publicado: (2020)

Regional trends in the use of steroids and favipiravir for COVID-19 treatment
por: Asai, Yusuke, et al.
Publicado: (2023)

1147. Regional Trends in Favipiravir and Steroid Use in the Treatment of COVID-19
por: Asai, Yusuke, et al.
Publicado: (2022)

233. Improved Penicillin Susceptibility of Streptococcus pneumoniae and Increased Penicillin Consumption in Japan, 2013–18
por: Tsuzuki, Shinya, et al.
Publicado: (2020)

Predictors of silent hypoxia in hospitalized patients with COVID-19 in Japan
por: Hayakawa, Kayoko, et al.
Publicado: (2022)

Decline in Antimicrobial Consumption and Stagnation in Reducing Disease Burden due to Antimicrobial Resistance in Japan
por: Tsuzuki, Shinya, et al.
Publicado: (2023)

First and second COVID-19 waves in Japan: A comparison of disease severity and characteristics
por: Saito, Sho, et al.
Publicado: (2021)

Clinical characteristics of COVID-19 in hospitalized children during the Omicron variant predominant period
por: Shoji, Kensuke, et al.
Publicado: (2022)

Clinical efficacy of remdesivir for COVID-19 in children: A propensity-score-matched analysis
por: Shoji, Kensuke, et al.
Publicado: (2023)

Risk factors for severity on admission and the disease progression during hospitalisation in a large cohort of patients with COVID-19 in Japan
por: Terada, Mari, et al.
Publicado: (2021)

2032. First National Survey of Antimicrobial and Antifungal Stewardship in Japan
por: Moriyama, Yuki, et al.
Publicado: (2019)

Clinical Epidemiology of Hospitalized Patients With Coronavirus Disease 2019 (COVID-19) in Japan: Report of the COVID-19 Registry Japan
por: Matsunaga, Nobuaki, et al.
Publicado: (2020)

Nationwide cross-sectional study of antimicrobial stewardship and antifungal stewardship programs in inpatient settings in Japan
por: Moriyama , Yuki, et al.
Publicado: (2021)

Comparison of clinical characteristics of COVID-19 in pregnant women between the Delta and Omicron variants of concern predominant periods
por: Shoji, Kensuke, et al.
Publicado: (2023)

1295. Cross-sectional survey on education of clinical infectious diseases and antimicrobial resistance in pharmaceutical department in Japanese universities
por: Koizumi, Ryuji, et al.
Publicado: (2022)

Predicting respiratory failure for COVID-19 patients in Japan: a simple clinical score for evaluating the need for hospitalisation
por: Yamada, Gen, et al.
Publicado: (2021)

Social contact patterns in Japan in the COVID-19 pandemic during and after the Tokyo Olympic Games
por: Tsuzuki, Shinya, et al.
Publicado: (2022)

Antimicrobial Use Fell Substantially in Japan in 2020—The COVID-19 Pandemic May Have Played a Role
por: Ono, Akane, et al.
Publicado: (2022)

Association between seasonal influenza vaccination and antimicrobial use in Japan from the 2015–16 to 2020–21 seasons: from the VENUS study
por: Tsuzuki, Shinya, et al.
Publicado: (2023)

2259. Reversal of antimicrobial consumption: long-term impact of COVID-19 pandemic
por: Koizumi, Ryuji, et al.
Publicado: (2023)

2473. Trends in Methicillin Resistance Rate of Staphylococcus aureus among Medical Facilities Participating in Japan Nosocomial Infections Surveillance (JANIS)
por: Suzuki, Yuka, et al.
Publicado: (2019)

Predictive model of risk factors of High Flow Nasal Cannula using machine learning in COVID-19
por: Matsunaga, Nobuaki, et al.
Publicado: (2022)

Effect of evacuation of Japanese residents from Wuhan, China, on preventing transmission of novel coronavirus infection: A modelling study
por: Asai, Yusuke, et al.
Publicado: (2021)

Considerations and concerns regarding the readiness to remove face coverings
por: Terada, Mari, et al.
Publicado: (2022)

Renin-angiotensin system blocker and the COVID-19 aggravation in patients with hypertension, diabetes, renal failure, Cerebro-cardiovascular disease, or pulmonary disease: Report by the COVID-19 Registry Japan
por: Yoshihara, Fumiki, et al.
Publicado: (2022)

Investigation of oral macrolide prescriptions in Japan using a retrospective claims database, 2013–2018
por: Ide, Satoshi, et al.
Publicado: (2023)

Cost of inappropriate antimicrobial use for upper respiratory infection in Japan
por: Tsuzuki, Shinya, et al.
Publicado: (2020)

2201. Cost of Antimicrobial Use Against Upper Respiratory Infection in Japan
por: Tsuzuki, Shinya, et al.
Publicado: (2019)

1193. Comparison of the Clinical Outcomes of Patients With IMP-Type Carbapenemase-Producing Carbapenem-Resistant Enterobacteriaceae and Carbapenem-Sensitive Enterobacteriaceae in Japan
por: Saito, Sho, et al.
Publicado: (2018)

1182. Risk Factors for the Acquisition of IMP-Type Carbapenemase-Producing Carbapenem-Resistant Enterobacteriaceae in Japan: A Matched Case–control Study
por: Saito, Sho, et al.
Publicado: (2018)

158. National Cross-Sectional Study of Factors Influencing the Decision of Prescribing Penicillin as First Choice among Dentists in Japan
por: Koizumi, Ryuji, et al.
Publicado: (2021)

Trends in healthcare visits and antimicrobial prescriptions for acute infectious diarrhea in individuals aged 65 years or younger in Japan from 2013 to 2018 based on administrative claims database: a retrospective observational study
por: Ono, Akane, et al.
Publicado: (2021)

Effectiveness of remdesivir in hospitalized nonsevere patients with COVID-19 in Japan: A large observational study using the COVID-19 Registry Japan
por: Tsuzuki, Shinya, et al.
Publicado: (2022)

Effectiveness of Favipiravir on Nonsevere, Early-Stage COVID-19 in Japan: A Large Observational Study Using the COVID-19 Registry Japan
por: Tsuzuki, Shinya, et al.
Publicado: (2022)

Risk factors associated with asymptomatic hypoxemia among COVID-19 patients: a retrospective study using the nationwide Japanese registry, COVIREGI-JP
por: Akiyama, Yutaro, et al.
Publicado: (2022)

2184. Surveillance System of Healthcare-Associated Infection in High and Upper-Middle Income Countries: A Scoping Review
por: Takaya, Saho, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_14js0v7ua7jo3sgv5h644mn6hv